Neurodegenerative diseases like Parkinson’s and Alzheimer’s affect millions of people and are becoming more common as the ...

Aging is the primary risk factor for neurodegenerative diseases, including Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis ...

After decades of setbacks, Alzheimer’s drug development is expanding beyond anti-amyloids, with a record number of trials and ...

Participants who chose not to learn their results said it would place a burden on themselves and their family members. As ...

Scientists identify stress granules as the potential root cause of Alzheimer's disease. This new understanding may ...

A study published in Cell Stem Cell reveals that some mutations in blood stem cells might help protect against late-onset ...

The Southeast — Kentucky, Tennessee, Alabama and Mississippi — had a 25% higher dementia diagnosis rate compared to the ...

Nuravax Inc., a clinical-stage biopharmaceutical company developing active immunotherapies for neurodegenerative diseases, announced today that two oral presentations—the Phase 1 clinical results and ...

New data hint at a role for the AS01 adjuvant in vaccines for herpes zoster and respiratory syncytial virus in protecting ...

Diabetics are more likely to develop Alzheimer’s than the general public. Could a popular diabetes and weight-loss drug also ...

Dementia rates vary dramatically across U.S. regions in ways that can't be explained by age, education, or health conditions.

While physical activity is known to slow cognitive decline in Alzheimer’s disease, many patients are unable to exercise due ...